In the use of immunopharmacotherapy to treat drug abuse, antigenic molecules are hitched to molecules of the drug to stimulate a future immune response against the drug itself; as DrugMonkey reported this week, a recently published paper offers hopeful evidence that it could be a potentially effective treatment against cocaine addiction, though he cautioned, "It is quite obviously not a silver bullet solution at present. And when you think about it a bit, it never will be." Later on, DrugMonkey looked at another study that tracked the contents of street ecstasy to determine how much actual MDMA each tablet contains in comparison to replacement psychoactive components like caffeine and ephedra. What's in that little white pill?
- Vaccination against cocaine: Incremental advance on DrugMonkey
- Longitudinal analysis of street Ecstasy content on DrugMonkey
- Log in to post comments
More like this
DrugMonkey responds to the outgoing Drug Czar's deep concerns about research with illegal drugs conducted with subjects who are addicted to those drugs, those concerns reported in an article in the Washington Examiner. From that article:
The federal government is giving crack and powder cocaine,…
Today's edition of the Journal of the American Medical Association
contains a study that employed PET scans to determine the effect of
modafinil upon dopamine concentration and reuptake in the human central
nervous system. They conclude with a caution that clinicians
should be mindful of the…
On December 14 (last week), the US National Institute on Drug Abuse (NIDA) released the findings on adolescent drug use and trends as determined from the 35th annual Monitoring the Future (MTF) survey (press release). The ambitious survey is conducted with NIDA funding* by the University of…
Back in August, I reported on an ACMD study buried in the back of a UK government report. The study gave strong evidence that the current drug classification scheme in the UK was fundamentally flawed and was not based on the actual danger of a given drug. The study has now been published in this…